NorthCrest Asset Manangement LLC Acquires 903 Shares of CME Group Inc. (NASDAQ:CME)

NorthCrest Asset Manangement LLC raised its holdings in shares of CME Group Inc. (NASDAQ:CME) by 9.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,507 shares of the financial services provider’s stock after buying an additional 903 shares during the quarter. NorthCrest Asset Manangement LLC’s holdings in CME Group were worth $2,318,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Salomon & Ludwin LLC bought a new position in shares of CME Group in the first quarter worth approximately $28,000. Y.D. More Investments Ltd bought a new position in shares of CME Group in the 2nd quarter worth $36,000. Thurston Springer Miller Herd & Titak Inc. raised its position in shares of CME Group by 62.2% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after buying an additional 74 shares in the last quarter. McClarren Financial Advisors Inc. lifted its holdings in shares of CME Group by 66.1% during the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after acquiring an additional 78 shares during the last quarter. Finally, Asset Dedication LLC lifted its holdings in shares of CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after acquiring an additional 170 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Down 1.5 %

NASDAQ CME opened at $226.14 on Friday. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $230.36. The stock has a market capitalization of $81.43 billion, a PE ratio of 25.73, a PEG ratio of 7.76 and a beta of 0.55. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The business’s 50-day moving average is $218.94 and its 200 day moving average is $208.89.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the company earned $2.25 EPS. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. Sell-side analysts forecast that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.03%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s payout ratio is currently 52.33%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Bank of America raised their price target on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. JPMorgan Chase & Co. raised their price objective on CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Oppenheimer upped their target price on CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research note on Thursday. Citigroup boosted their price objective on shares of CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a report on Thursday. Finally, Piper Sandler increased their target price on shares of CME Group from $225.00 to $240.00 and gave the company an “overweight” rating in a report on Tuesday, October 8th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $222.07.

Insiders Place Their Bets

In other news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares in the company, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.